Skip to main content

Table 3 Correlation of EZH2 mRNA expression with the clinicopathological factors of esophageal carcinoma patients

From: Elevated expression of RUNX3 co-expressing with EZH2 in esophageal cancer patients from India

Clinicopathological parameters No. of patients EZH2 expression relative to β-Actin p-value
Age    
 ≥ 50 40 6.53 ± 1.4 0.595
 < 50 12 6.61 ± 1.9  
Sex    
 Male 31 6.47 ± 1.4 0.751
 Female 21 6.66 ± 1.6  
Classification    
 Locally advanced resectable 25 6.59 ± 1.5  
 Locally advanced unresectable 23 6.63 ± 1.6 0.532
 Metastatic 4 5.79 ± 1.1  
Dysphagia Grade    
 dys Gr1 1 6.34 ± 0  
 dys Gr2 18 6.31 ± 1.5  
 dys Gr3 21 6.96 ± 1.5 0.314
 dys Gr4 11 6.41 ± 1.2  
 dys Gr5 1 3.83 ± 0  
Location of Tumor    
 Upper third 7 6.28 ± 1.9  
 Middle third 24 6.67 ± 1.6 0.799
 Lower third 21 6.51 ± 1.2  
Smoking    
 Smoker 30 6.51 ± 1.3 0.803
 Non-smoker 22 6.60 ± 1.7  
Alcohol    
 Alcoholic 20 6.58 ± 1.6 0.94
 Non-Alcoholic 32 6.53 ± 1.5  
Tobacco    
 Tobacco Chewer 5 6.32 ± 1.2 0.78
 Non-Tobacco Chewer 47 6.57 ± 1.5  
Type    
 SCC 47 6.58 ± 1.5 0.609
 Adeno 5 6.19 ± 0.8  
Diet    
 Veg 28 6.33 ± 1.3 0.233
 NonVeg 24 6.80 ± 1.6